tiprankstipranks
Trending News
More News >
Mapfre, SA (ES:MAP)
BME:MAP

Mapfre, SA (MAP) AI Stock Analysis

Compare
66 Followers

Top Page

ES

Mapfre, SA

(BME:MAP)

Rating:71Outperform
Price Target:
€4.00
▲(13.64%Upside)
Mapfre, SA scores a 71, driven primarily by its stable financial performance and attractive valuation. The technical analysis indicates a positive trend, supporting the stock's potential for price appreciation. However, the company's past cash flow challenges and inconsistent revenue growth present areas for potential risk. The absence of new earnings call insights or notable corporate events means that these components do not impact the score.

Mapfre, SA (MAP) vs. iShares MSCI Spain ETF (EWP)

Mapfre, SA Business Overview & Revenue Model

Company DescriptionMapfre, S.A., engages in the insurance and reinsurance activities worldwide. It offers life, health, accident, savings and investment, retirement, burial, and travel and leisure insurance; and homeowner's, automobile, third-party liability, family, and other insurance. The company also provides vehicle, third-party liability and asset, agriculture and livestock, commercial establishment, and other insurance products. In addition, it offers engineering and building, hull and aviation, transportation of goods, surety and credit, life and retirement, and other insurances and reinsurance products. The company offers its services to individuals, professionals, entrepreneurs, self-employed people, small and medium-sized enterprises, and large corporations. It distributes its products through a network of 4,942 direct and delegates; and 10,412 bancassurance offices, as well as through 77,754 delegates, agents, and brokers. The company was formerly known as Corporacion Mapfre and changed its name to Mapfre, S.A. in December 2006. Mapfre, S.A. was founded in 1933 and is headquartered in Majadahonda, Spain. Mapfre, S.A. operates as a subsidiary of Cartera Mapfre, S.L.
How the Company Makes MoneyMapfre, SA generates revenue primarily through the underwriting of insurance policies across multiple sectors, including life, non-life, and health insurance. The company earns money from the premiums paid by policyholders for these insurance products. Additionally, Mapfre invests the premiums it collects into financial markets, generating income from investment returns. The company's revenue streams also include fees and commissions from various financial and insurance-related services. Strategic partnerships and collaborations with other financial institutions and a robust distribution network further enhance Mapfre's ability to reach a broad customer base, thereby driving its earnings.

Mapfre, SA Financial Statement Overview

Summary
Mapfre, SA demonstrates a solid but fluctuating financial performance. The company's strengths lie in its stable balance sheet and high gross profit margins. However, inconsistencies in revenue growth and past cash flow challenges highlight areas for improvement. A focus on enhancing profitability and cash flow stability could bolster overall financial health.
Income Statement
65
Positive
Mapfre, SA shows moderate performance in its income statement. The Gross Profit Margin is consistently high, as expected in the insurance industry. However, the Net Profit Margin is relatively modest, indicating room for improvement in profitability. The revenue growth rate has been inconsistent, with fluctuations over the years, which suggests challenges in maintaining a steady growth trajectory. The absence of EBIT and EBITDA data for 2024 limits the analysis of operational efficiency for the latest year.
Balance Sheet
72
Positive
The company's balance sheet reflects a stable financial position with a moderate Debt-to-Equity Ratio, indicating a balanced approach to leverage. Return on Equity (ROE) has shown variability, but the company maintains a solid Equity Ratio, suggesting a strong capital structure. However, the fluctuations in total assets and liabilities over the years point to potential volatility in financial stability.
Cash Flow
58
Neutral
The cash flow statement reveals some strengths and weaknesses. Free Cash Flow has shown growth in recent years, but past negative free cash flows highlight potential challenges in cash management. The Operating Cash Flow to Net Income Ratio is unavailable for the latest year, limiting insights into operational cash generation efficiency. Historical fluctuations in cash flow metrics suggest potential risks in maintaining consistent cash flow stability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue27.85B25.83B27.13B21.56B20.58B19.15B
Gross Profit30.92B25.83B27.13B21.56B20.58B19.15B
EBITDA539.50M2.13B1.92B1.52B1.66B1.42B
Net Income871.00M967.50M677.20M1.08B1.04B820.70M
Balance Sheet
Total Assets54.62B56.71B54.95B59.63B63.85B69.15B
Cash, Cash Equivalents and Short-Term Investments1.65B24.93B2.09B28.08B32.28B32.80B
Total Debt2.72B2.57B3.05B4.64B4.91B4.83B
Total Liabilities44.94B46.72B45.29B51.27B54.19B59.31B
Stockholders Equity8.54B8.89B8.47B7.29B8.46B8.54B
Cash Flow
Free Cash Flow0.001.21B1.40B854.30M-611.60M-884.50M
Operating Cash Flow0.001.50B1.62B1.08B-485.90M-596.10M
Investing Cash Flow0.00-746.90M-673.60M-198.50M1.31B1.18B
Financing Cash Flow0.00-1.09B-1.18B-724.30M-369.40M-570.00M

Mapfre, SA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.52
Price Trends
50DMA
3.33
Positive
100DMA
3.02
Positive
200DMA
2.74
Positive
Market Momentum
MACD
0.06
Negative
RSI
68.61
Neutral
STOCH
88.90
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ES:MAP, the sentiment is Positive. The current price of 3.52 is above the 20-day moving average (MA) of 3.38, above the 50-day MA of 3.33, and above the 200-day MA of 2.74, indicating a bullish trend. The MACD of 0.06 indicates Negative momentum. The RSI at 68.61 is Neutral, neither overbought nor oversold. The STOCH value of 88.90 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ES:MAP.

Mapfre, SA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
ESMAP
71
Outperform
€10.54B10.96
4.70%
57
Neutral
$5.79B25.71-31.22%5.61%10.88%-29.73%
€5.81B9.1311.73%4.82%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ES:MAP
Mapfre, SA
3.52
1.47
71.73%
GB:0NRN
Grupo Catalana Occidente
49.20
11.95
32.08%

Mapfre, SA Corporate Events

MAPFRE Reports Strong Solvency Ratio for Q1 2025
May 21, 2025

MAPFRE, S.A. reported a solvency ratio of 205.6% at the end of the first quarter of 2025, indicating robust financial health. The company’s eligible own funds reached 10,051 million euros, with 84% being high-quality funds. This strong solvency position is within the target range set by the Board of Directors and reflects MAPFRE’s commitment to financial stability and risk management, which is crucial for stakeholders and the company’s market positioning.

The most recent analyst rating on (ES:MAP) stock is a Hold with a EUR3.05 price target. To see the full list of analyst forecasts on Mapfre, SA stock, see the ES:MAP Stock Forecast page.

Mapfre Announces 2024 Fiscal Year Dividend Details
May 19, 2025

Mapfre, S.A. has announced a complementary dividend of 0.0952 euros gross per share for the fiscal year 2024, with key dates for trading and payment set in late May 2025. This decision reflects Mapfre’s commitment to returning value to its shareholders and may enhance its attractiveness in the financial markets.

The most recent analyst rating on (ES:MAP) stock is a Hold with a EUR3.05 price target. To see the full list of analyst forecasts on Mapfre, SA stock, see the ES:MAP Stock Forecast page.

MAPFRE to Distribute Complementary Dividend for 2024 Fiscal Year
Apr 25, 2025

MAPFRE, S.A. has announced that it will distribute a complementary dividend of 0.095 euros gross per share on May 29, 2025, based on the 2024 fiscal year results. This decision, approved by the Board of Directors, reflects the company’s commitment to returning value to its shareholders and is set to be executed through BANCO SANTANDER, S.A. as the paying agent. The announcement outlines important dates for shareholders, including the last trading date with dividend rights on May 26, 2025, and the ex-dividend date on May 27, 2025.

MAPFRE Reports Strong Q1 2025 Results with 27.6% Profit Increase
Apr 25, 2025

MAPFRE has reported a significant increase in profits for the first quarter of 2025, achieving a profit of 276 million euros, which is a 27.6% increase from the previous year. This growth is attributed to the successful implementation of its Strategic Plan, with premiums growing by 5.4% and improvements in the Non-Life and Automobile business lines. The company’s performance across different regions, including IBERIA, NORTH AMERICA, and LATAM, has been strong, contributing to a robust financial outlook for 2025. The company plans to pay a complementary dividend for the 2024 fiscal year, reflecting its confidence in future growth.

MAPFRE Announces Investor Teleconference for Q1 2025 Review
Apr 8, 2025

MAPFRE, S.A. has announced a teleconference scheduled for April 25, 2025, aimed at investors and analysts to discuss the company’s first-quarter activities. This event, accessible via streaming on their corporate website, signifies MAPFRE’s commitment to transparency and engagement with stakeholders, potentially impacting investor relations and market perception.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 25, 2025